Generic Safety, Inc. is committed to inform every American concerning a recent Supreme Court decision, PLIVA, Inc. v. Mensing, 131 S. Ct. 2567 (2011) exempting generic prescription manufacturers from being sued for product liability. 

Justice Sotomayor, dissenting, wrote, "as the majority itself admits, a drug consumer’s right to compensation for inadequate warnings now turns on the happenstance of whether her pharmacist filled her prescription with a brand-name drug or a generic". 

According to a report from the IMS, Institute for Healthcare Informatics,  78% of the nearly 4 billion U.S. prescriptions written in 2010 were for generic drugs (both unbranded and those still sold under a brand name). That means that 3.1 billion prescriptions written in the U.S. annually are not covered by any product liability protection by the manufacturer.

Through outreach and advocacy, we will make a difference! We regularly meet with legislators, bloggers, physicians, and support candidates that support our vision.

We rely on private financial donations to support the cause as well as volunteers. Click on the DONATIONS page to make a donation, or contact us if you'd like to volunteer to spread the word in cyberspace.


Gregory F. Welsh
Founder and CEO

Contact us Today! (info@genericsafety.org)